Clinical Trials

166 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT01248247 2022-01-12

BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

334 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00954278 2019-11-15

Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer

24 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00647426 2019-10-22

Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC

7 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT00754923 2019-03-06

Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Terminated

11 enrolled 8 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00547443 2019-01-10

Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00543335 2018-11-15

Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

Phase 1 Terminated

10 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00801801 2017-05-17

Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC

Phase 2 Terminated

5 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT00454194 2017-03-21

Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

110 enrolled 15 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01005797 2017-03-03

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

GenitourinarySarcomaThoracic

38 enrolled

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Sarcoma

NCT00417248 2016-07-25

Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer

Phase 1/2 Terminated

8 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung

NCT00933777 2016-05-25

SORAVE

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00609804 2016-04-08

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

53 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT00411671 2016-02-11

BATTLE Program: Sorafenib in Patients With NSCLC

105 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00533585 2016-02-10

BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)

23 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

NCT00870532 2013-11-04

Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer

52 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00922584 2013-08-21

Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor

65 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00635791 2013-06-20

Phase I Study of Vorinostat and Sorafenib in Advanced Cancer

36 enrolled

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell

NCT00473486 2010-01-27

PECASO

Phase 1/2 Terminated

12 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00722969 2009-03-03

Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Phase 2 Unknown

48 enrolled